安科生物：高管计划减持100万股

Core Viewpoint - Anke Biological announced that senior management personnel Yao Jianping plans to reduce his holdings by up to 1 million shares, representing 0.06% of the company's total share capital, due to personal financial needs [1] Summary by Relevant Sections - Shareholding Details - Yao Jianping currently holds 6.7622 million shares, accounting for 0.40% of the company's total shares [1] - Reduction Plan - The planned reduction will take place from September 26, 2025, to December 25, 2025, through centralized bidding or block trading [1] - Source of Shares - The shares to be reduced are sourced from shares issued prior to the company's initial public offering and from the capital reserve converted into share capital [1]